- Investing Ideas
- German Pharmaceuticals & Biotech Undervalued over 20% based on DCF
German Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
3
0 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
3 companies
SCHOTT Pharma KGaA
Market Cap: €2.1b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€13.70
7D
1.5%
1Y
-35.8%
Gerresheimer
Market Cap: €641.1m
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€18.56
7D
-9.8%
1Y
-66.3%
Formycon
Market Cap: €328.9m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.62
7D
5.4%
1Y
-18.7%